High-energy Human Milk Diets in the First Two Weeks After Birth to Reduce BPD in Extremely Preterm Infants

Starting soon · Phase 1/Phase 2

Conditions studied: Extreme Prematurity, Enteral Nutrition, Bronchopulmonary Dysplasia

In brief

This Phase II, parallel-group, masked, randomized clinical trial aims to evaluate whether a DHA/ARA-enriched, fortified human milk diet administered during the first 14 days of life reduces respiratory morbidity and improves lung function in extremely preterm (EPT) infants (born at ≤28 weeks gestation).

Key facts

Study ID

NCT07307612

Run by

University of Alabama at Birmingham

People needed

150

Starts

2026-08-15

Expected to finish

2029-07-31

Last updated by the study team

2026-06-12

Who can join

Age: 0 and older, up to 0. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Gestational age ≤ 28 weeks of gestation
• Postnatal age < 72 hours

You may not qualify if…

• Congenital malformations
• Chromosomal anomalies
• Terminal illness needing to limit or withhold support

Where it is running

• University of Alabama at Birmingham — Birmingham, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.